Abstract
Radiotherapy Sensitization Enhancing the cellular radiosensitivity is instrumental for improving the efficacy of tumor radiotherapy. In article number 2206415, Junping Wang, Cheng Wang, and co-workers report a tumor-penetrating nanomaterial iCoDMSN constituted with dendritic mesoporous silica nanoparticles and iRGD peptide-conjugated [email protected] nanodots. By decreasing KEAP1 expression and upregulating nuclear factor erythroid 2-related factor 2 (NRF2) and heme oxygenase 1 (HMOX1), iCoDMSN expands the labile iron pool in cancer cells and initiates ferroptosis, whereby the nanomaterial sensitizes cancer cells to ionized radiation and eliminates the tumors combined with radiotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
